Physician profile
Katie E Combs
NPI 1518155761
$1,493.08
in general payments reported to CMS, 2019-2025
20 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $311 · 2022: $527 · 2023: $252 · 2024: $295 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $345.06 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $224.12 | 2021-2025 | Wegovy |
| Abbvie INC. | $177.83 | 2022 | |
| Sumitomo Pharma America, INC. | $171.68 | 2023-2024 | Gemtesa |
| Amgen INC. | $69.02 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.46 | 2022 | |
| Currax Pharmaceuticals LLC | $59.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $55.05 | 2021-2022 | |
| Abbott Laboratories | $45.81 | 2022-2024 | Freestyle Libre 3 |
| Pfizer INC. | $43.75 | 2022-2024 | |
| Medtronic, INC. | $41.31 | 2023-2024 | Interstim, Nuro |
| Lilly USA, LLC | $33.69 | 2024-2025 | Kisunla, Jardiance, Zepbound |
| Medicure Pharma INC. | $27.35 | 2021 | |
| Optinose US, INC. | $26.23 | 2025 | |
| Boston Scientific Corporation | $22.89 | 2023 | Ams 700 Cxr Rte Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $20.27 | 2022 | |
| Chiesi USA, INC. | $18.13 | 2025 | Elfabrio |
| Radius Health, INC. | $17.77 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.28 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.